Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Why The Monash Group IVF Ltd (ASX:MVF) Share Price Could Fall

The Monash IVF Group Ltd (ASX:MVF) share price could fall after NSW Premier Gladys Berejiklian announced a $42 million package for IVF treatment.

The Monash IVF Group Ltd (ASX: MVF) share price could fall after NSW Premier Gladys Berejiklian announced a possible $42 million package for IVF treatment in NSW if her government is re-elected.

The package would see a rebate of up to $500 for pre-IVF fertility testing, with Ms. Berejiklian stating, “we will provide assistance with out-of-pocket medical expenses related to IVF pre-screening which is often an expensive and emotionally challenging experience for women”.

The Premier also stated that the Government will expand on government-supported IVF services which is only currently available at the Royal Prince Alfred hospital, saying, “we will also make IVF an option for more women who previously may not have been able to afford it by expanding the number of NSW Government supported IVF clinics”.

If re-elected, the services would also be available at Westmead Hospital and The Royal Hospital for Women, which will provide lower cost treatments for around 6,000 women.

What Does This Mean for Monash IVF?

As I have previously said, Monash IVF’s margins have been declining as cheaper and alternative ways of accessing IVF treatment become more readily available in Australia. It’s becoming clear that there is no real competitive advantage for Monash IVF and further erosion of margins and profit may continue in the foreseeable future.

Rask Perspective

This is just further evidence of the increased competition in Australia for IVF treatment in a more cost-effective way. While NSW is only one state in the country, providing treatment for up to 6,000 women is almost half of what Monash IVF service nationally in a year so it could potentially have a big impact.

There is no real competitive advantage for Monash IVF and I believe it to be a company to steer clear of adding to a share portfolio. There are plenty of other companies out there with a more enduring competitive advantage that can provide better returns over time.

[ls_content_block id=”14945″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content